Characteristics and Outcome of Patients with Acute Myeloid Leukemia and Trisomy 4

被引：0

作者：

Kayser, Sabine ^{[1
,2
]}

Martinez-Cuadron, David ^{[3
,4
]}

Hanoun, Maher ^{[5
]}

Stoelzel, Friedrich ^{[6
]}

Gil, Cristina ^{[7
]}

Reinhardt, H. Christian ^{[8
]}

Aguiar, Eliana ^{[9
]}

Schaefer-Eckart, Kerstin ^{[10
]}

Bergua Burgues, Juan Miguel ^{[11
]}

Steffen, Bjoern ^{[12
]}

Bernal, Teresa ^{[13
]}

Krause, Stefan W. ^{[14
]}

Riaza, Rosalia ^{[15
]}

Schliemann, Christoph ^{[16
]}

Cervera, Jose ^{[17
]}

Kaufmann, Martin ^{[18
,19
]}

Torres, Laura ^{[17
,20
]}

Haenel, Mathias ^{[21
]}

Acuna-Cruz, Evelyn ^{[22
]}

Jost, Edgar ^{[23
]}

Lorenzo Algarra, Jesus ^{[24
]}

Crysandt, Martina ^{[25
]}

Fransecky, Lars ^{[26
]}

Cornago Navascues, Javier ^{[27
]}

Kraus, Sabrina ^{[28
]}

Martinez-Lopez, Joaquin ^{[29
]}

Einsele, Hermann ^{[30
]}

Niemann, Dirk ^{[31
]}

Neubauer, Andreas ^{[32
]}

Seggewiss-Bernhardt, Ruth ^{[33
]}

Scholl, Sebastian ^{[34
]}

Klein, Stefan ^{[35
]}

Schmid, Christoph ^{[36
]}

Schaich, Markus ^{[37
]}

Schmidt-Hieber, Martin ^{[38
]}

Ho, Anthony D. ^{[39
]}

Platzbecker, Uwe ^{[40
]}

Claudia, D. Baldus ^{[26
]}

Mueller-Tidow, Carsten ^{[39
]}

Thiede, Christian ^{[41
]}

Bornhaeuser, Martin ^{[42
]}

Serve, Hubert ^{[43
]}

Levis, Mark ^{[44
]}

Montesinos, Pau ^{[45
,46
]}

Roellig, Christoph ^{[41
]}

Schlenk, Richard F. ^{[47
,48
]}

机构：

[1] Univ Hosp Leipzig, Hematol & Cellular Therapy, Leipzig, Germany

[2] German Canc Res Ctr, Heidelberg, Germany

[3] CIBERONC Inst Salud Carlos III, Madrid, Spain

[4] Hosp Univ Politecn La Fe, Inst Invest Sanitaria La Fe IISLAFE, Valencia, Spain

[5] Univ Hosp Essen, Dept Hematol & Stem Cell Transplantat, Essen, Germany

[6] TU Dre, Univ Hosp Carl Gustav Carus, Dept Internal Med 1, Dresden, Germany

[7] Hosp Gen Univ Alicante, Alicante, Spain

[8] Univ Hosp Essen, Dept Hematol & Stem Cell Transplantat, Essen, Germany

[9] Hosp Sao Joao Oporto, Clin Haematol Dept, Porto, Portugal

[10] Hosp Nurnberg, Dept Internal Med 5, Nurnberg, Germany

[11] Hosp San Pedro Acantara, Hematol Dept, Caceres, Spain

[12] Goethe Univ, Univ Hosp, Dept Med 2, Hematol Oncol, Frankfurt, Germany

[13] Inst Univ IUOPA, Inst Invest Principado Asturias ISPA, Hosp Univ Cent Asturias, Oviedo, Spain

[14] Univ Hosp Erlangen, Dept Hematol & Med Oncol, Erlangen, Germany

[15] Hosp Univ Severo Ochoa, Hematol Dept, Madrid, Spain

[16] Univ Hosp Muenster, Dept Med A Hematol Oncol & Pneumol, Munster, Germany

[17] Inst Carlos III, CIBERONC, Madrid, Spain

[18] Hosp Univ La Fe, Valencia, Spain

[19] Robert Bosch Krankenhaus, Dept Hematol Oncol & Palliat Med, Stuttgart, Germany

[20] Hosp Univ La Fe Valencia, Hematol Dept, Valencia, Spain

[21] Chemnitz Hosp, Dept Internal Med 3, Chemnitz, Germany

[22] Hosp Univ i Politecn La Fe, Valencia, Spain

[23] Univ Hosp Aachen, Med Fac, Dept Hematol Oncol Hemostaseol & Stem Cell Transp, Aachen, Germany

[24] Complejo Hosp Univ Albacete, Hematol Dept, Albacete, Spain

[25] Univ Hosp RWTH Aachen, Dept Hematol Oncol Hemostaseol & Stem Cell Transp, Fac Med, Aachen, Germany

[26] Univ Hosp Schleswig Holstein, Dept Internal Med 2, Kiel, Germany

[27] Hosp Univ Fdn Jimenez Diaz, Hematol & Hemotherapy Dept, Valencia, Spain

[28] Univ Hosp Wuerzburg, Dept Med 2, Wurzburg, Germany

[29] Univ Complutense Madrid, Hosp 12 Octubre, Dept Hematol, CNIO, Madrid, Spain

[30] Wurzburg Univ Hosp, Div Oncol & Hematol, Dept Internal Med 2, Wurzburg, Germany

[31] Ev Stift St Martin, Dept Hematol Oncol & Palliat Med, Koblenz, Germany

[32] Univ Hosp Marburg, Dept Hematol Oncol & Immunol, Marburg, Germany

[33] Sozialstiftung Bamberg, Med Klin 5, Bamberg, Germany

[34] Univ Hosp Jena, Dept Internal Med Hematol & Oncol 2, Jena, Germany

[35] Univ Hosp Mannheim, Dept Hematol & Oncol, Mannheim, Germany

[36] Augsburg Univ Hosp & Med Fac, Dept Hematol & Oncol Stem Cell Transplantat, Augsburg, Germany

[37] Rems Murr Klinikum Winnenden, Dept Hematol Oncol & Palliat Med, Winnenden, Germany

[38] Carl Thiem Klinikum, Dept Hematol & Oncol, Cottbus, Germany

[39] Univ Heidelberg Hosp, Dept Internal Med 5, Heidelberg, Germany

[40] Univ Hosp Leipzig, Dept Hematol Cellular Therapy & Hemostaseol, Leipzig, Germany

[41] Univ Hosp Carl Gustav Carus, Dept Internal Med 1, Dresden, Germany

[42] Univ Hosp Dresden, Dept Internal Med 1, Dresden, Germany

[43] Goethe Univ, Univ Hosp Frankfurt, Dept Med Hematol & Oncol 2, Frankfurt, Germany

[44] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[45] Hosp Univ i Politecn La Fe, Valencia, Spain

[46] CIBERONC Inst Salud Carlos III, Valencia, Spain

[47] Univ Hosp Heidelberg, Dept Hematol Oncol & Rheumatol, Heidelberg, Germany

[48] German Canc Res Ctr, Natl Ctr Tumor Dis, NCT Trial Ctr, Heidelberg, Germany

来源：

BLOOD | 2021年 / 138卷

关键词：

D O I：

10.1182/blood-2021-150281

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1307

引用

页数：6

共 50 条

[21] Hyperleukocytosis in Patients with Acute Myeloid Leukemia Characteristics and Outcome, a Single-Center Experience
Mohamed, Shehab
Shawayli, Hawra
Abbas, Feryal
Soliman, Dina Sameh
Afana, Mohammad
Yassin, Mohamed A.
Mudawi, Deena
Elsabah, Hesham
Kohla, Samah Ahmed Samy
Mulikandathil, Yahya
Amer, Aliaa
Alshurafa, Awni Alshurafa
Singh, Kalpana
El Omri, Halima
Gameil, Amna
Cherif, Honar
BLOOD, 2023, 142
[22] Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia
Schlenk, R. F.
Frech, P.
Weber, D.
Brossart, P.
Horst, H-A
Kraemer, D.
Held, G.
Ringhoffer, M.
Burchardt, A.
Kobbe, G.
Goetze, K.
Nachbaur, D.
Fischer, T.
Luebbert, M.
Salih, H. R.
Salwender, H.
Wulf, G.
Koller, E.
Wattad, M.
Fiedler, W.
Kremers, S.
Kirchen, H.
Hertenstein, B.
Paschka, P.
Gaidzik, V. I.
Teleanu, V.
Heuser, M.
Thol, F.
Doehner, K.
Krauter, J.
Ganser, A.
Doehner, H.
LEUKEMIA, 2017, 31 (05) : 1217 - 1220
[23] Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil
Oliveira, L. C. O.
Romano, L. G. M.
Prado-Junior, B. P. A.
Covas, D. T.
Rego, E. M.
De Santis, G. C.
MEDICAL ONCOLOGY, 2010, 27 (04) : 1254 - 1259
[24] Outcome of Refractory and Relapsed Patients with Acute Myeloid Leukemia
Niederwieser, Dietger
Krahl, Rainer
Kahle, Christoph
Scholl, Sebastian
Wolf, Hans-Heinrich
Cross, Michael
Hegenbart, Ute
Peter, Norma
Niederwieser, Christian
Florschuetz, Axel
Reifenrath, Kolja F. B.
Zojer, Niklas
Junghanss, Christian
Sayer, Herbert
Schmidt, Volker
Maschmeyer, Georg
Hochhaus, Andreas
Fischer, Thomas
Al-Ali, Haifa Kathrin
Heinicke, Thomas
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 106 - 106
[25] Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil
L. C. O. Oliveira
L. G. M. Romano
B. P. A. Prado-Junior
D. T. Covas
E. M. Rego
G. C. De Santis
Medical Oncology, 2010, 27 : 1254 - 1259
[26] Characteristics and outcome of epipodophyllotoxin-related acute myeloid leukemia
Pui, CH
Relling, MV
Rivera, GK
Hancock, ML
Raimondi, SC
Heslop, HE
Santana, VM
Ribeiro, RC
Sandlund, JT
Mahmoud, HH
Evans, WE
Crist, WM
Krance, RA
BLOOD, 1995, 86 (10) : 1055 - 1055
[27] Late relapses in acute myeloid leukemia: analysis of characteristics and outcome
Verma, Dushyant
Kantarjian, Hagop
Faderl, Stefan
O'Brien, Susan
Pierce, Sherry
Vu, Khanh
Freireich, Emil
Keating, Michael
Cortes, Jorge
Ravandi, Farhad
LEUKEMIA & LYMPHOMA, 2010, 51 (05) : 778 - 782
[28] Prognostic significance of trisomy 4 as the sole cytogenetic abnormality in acute myeloid leukemia
Gupta, V
Minden, MD
Yi, QL
Brandwein, J
Chun, K
LEUKEMIA RESEARCH, 2003, 27 (11) : 983 - 991
[29] 2 FURTHER CASES OF ACUTE MYELOID-LEUKEMIA WITH TRISOMY-4
HOYLE, CF
BOUGHTON, BJ
HAYHOE, FGJ
CANCER GENETICS AND CYTOGENETICS, 1988, 34 (01) : 29 - 32
[30] Adolescents and young adults with acute lymphoblastic leukemia and acute myeloid leukemia: Characteristics and treatment outcome
Ampatzidou M.
Kelaidi C.
Dworzak M.N.
Polychronopoulou S.
memo - Magazine of European Medical Oncology, 2018, 11 (1) : 47 - 53

← 1 2 3 4 5 →